Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

High Histone Deacetylase 2/3 Expression in Non-Functioning Pituitary Tumors

Frontiers in Oncology(2022)10.3389/fonc.2022.875122Source: DataRank Database

High Histone Deacetylase 2/3 Expression in Non-Functioning Pituitary Tumors is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (11)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Xiaobin Jiang ORCID,Karrin Weisenthal,Jun Ma ORCID,Erin M. Botticelli,Yunli Zhou ORCID

Live enrichment

PubMed:35646715 PMC:PMC9136140

NCI NIH HHS

Grant: R01 CA193520

National Institutes of Health

Grant: 5R01CA193520-02

The Role of lncRNA MEG3 in Clinically Non-functioning Pituitary Adenomas

Jarislowsky Foundation

National Institutes of Health

goldLicense: cc-by

publisherhttps://doi.org/10.3389/fonc.2022.875122

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2022.875122/full

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9136140

Europe_PMChttps://europepmc.org/articles/PMC9136140

Europe_PMChttps://europepmc.org/articles/PMC9136140?pdf=render

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicine

Keywords

Growth suppressionEpigenetic ModificationsClass I Histone DeacetylasesHuman Clinically Non-Functioning Pituitary AdenomasRegulation Of Tumor Suppressor ExpressionsOncologyNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of Therapeutic potential of targeting Nrf2 by panobinostat in pituitary neuroendocrine tumors

10.6084/m9.figshare.25649338.v1figshare

Additional file 1 of Therapeutic potential of targeting Nrf2 by panobinostat in pituitary neuroendocrine tumors

10.6084/m9.figshare.25649338figshare